Pure Health Holding PJSC (ADX:PUREHEALTH) EBITDA Margin %: 16.39% (As of Mar. 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADX:PUREHEALTH Pure Health Holding PJSC ADX:PUREHEALTH
25 GF Score
Price د.إ2.23
! 4 Warning Signs
View Full Analysis

What is Pure Health Holding PJSC EBITDA Margin %?

Pure Health Holding PJSC ADX:PUREHEALTH 25 EBITDA Margin % is 16.39% as of Mar. 2026, which is 4% below its 10-year median of 17.03. GuruFocus rates ADX:PUREHEALTH with a GF Score™ of 25/100. The stock has 4 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Pure Health Holding PJSC ranks better than 68.52% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Pure Health Holding PJSC's EBITDA for the three months ended in Mar. 2026 was د.إ1,190 Mil. Pure Health Holding PJSC's Revenue for the three months ended in Mar. 2026 was د.إ7,262 Mil. Therefore, Pure Health Holding PJSC's EBITDA margin for the quarter that ended in Mar. 2026 was 16.39%.


Pure Health Holding PJSC  (ADX:PUREHEALTH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Pure Health Holding PJSC EBITDA Margin % Related Terms


Pure Health Holding PJSC EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Pure Health Holding PJSC's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pure Health Holding PJSC EBITDA Margin % Chart

Pure Health Holding PJSC Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
0.00 37.73 14.80 16.11 17.95

Pure Health Holding PJSC Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.77 17.28 18.00 18.74 16.39

ADX:PUREHEALTH vs HCA, THC, DVA: EBITDA Margin % Comparison

For the Medical Care Facilities subindustry, Pure Health Holding PJSC's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pure Health Holding PJSC EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pure Health Holding PJSC's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Pure Health Holding PJSC's EBITDA Margin % falls into.


ADX:PUREHEALTH
25GF Score
Pure Health Holding PJSC ADX:PUREHEALTH
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pure Health Holding PJSC EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Pure Health Holding PJSC's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=4903.637/27311.962
=17.95 %

Pure Health Holding PJSC's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=1190.352/7262.331
=16.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 16.39% mean?
Pure Health Holding PJSC (ADX:PUREHEALTH) has a EBITDA Margin % of 16.39% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Pure Health Holding PJSC and its competitors. This is near median its historical median of 17.03. Over the past decade, Pure Health Holding PJSC's EBITDA Margin % has ranged from 14.80 to 37.73. According to the industry distribution chart, Pure Health Holding PJSC ranks #209 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 31.5%.
Is Pure Health Holding PJSC's EBITDA Margin % too high?
Pure Health Holding PJSC's current EBITDA Margin % of 16.39% is near median its 10-year median of 17.03. Over the past 10 years, this metric has ranged from a low of 14.80 to a high of 37.73. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Pure Health Holding PJSC's value of 16.39% is 60.5% above this industry median. Based on the distribution chart, Pure Health Holding PJSC ranks #209 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Pure Health Holding PJSC has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Pure Health Holding PJSC's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Pure Health Holding PJSC ranks #209 out of 664 companies for EBITDA Margin %. This puts Pure Health Holding PJSC in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Pure Health Holding PJSC's value of 16.39% is 60.5% above this benchmark. Historically, Pure Health Holding PJSC's own EBITDA Margin % has ranged from 14.80 to 37.73 over the past decade. While the company's 10-year median is 17.03 vs. the industry median of 10.21, Pure Health Holding PJSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pure Health Holding PJSC's current EBITDA Margin % of 16.39% is 60.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Pure Health Holding PJSC and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pure Health Holding PJSC's current EBITDA Margin % is 16.39%, which is near median its own 10-year median of 17.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pure Health Holding PJSC stock overvalued right now?
Pure Health Holding PJSC (ADX:PUREHEALTH) has a current EBITDA Margin % of 16.39%. The current EBITDA Margin % is 16.39%, which is near median its 10-year median of 17.03 and 60.5% above the Healthcare Providers & Services industry median of 10.21. Pure Health Holding PJSC's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Pure Health Holding PJSC (ADX:PUREHEALTH), the current EBITDA Margin % is 16.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pure Health Holding PJSC Business Description

Address Al Rahah Street, Aldar Headquarters Building, Abu Dhabi, ARE
Pure Health Holding PJSC is an integrated healthcare company in the United Arab Emirates with a cross-category ecosystem covering hospitals, clinics, diagnostics, insurance, pharmacies, research, health tech, and procurement, along with an international footprint in the United States and the United Kingdom. The company's reportable segments are Hospital and other healthcare related services, Health Insurance services, Diagnostic services, and Technology services and others. Key revenue is derived from the Hospital and other healthcare related services segment through which it provides general healthcare operations, including hospitalization, clinical, isolation/quarantine, vaccinations, and other services.
25GF Score

Get the complete analysis for ADX:PUREHEALTH

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

د.إ2.23
Price